Literature DB >> 17693606

The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosis.

Dieter E Jenne, Peer M Aries, Simon Einwächter, Amer D Akkad, Stefan Wieczorek, Peter Lamprecht, Wolfgang L Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17693606      PMCID： PMC1955148          DOI： 10.1136/ard.2006.065987

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS.

Authors:  B G Weinshenker; D Hebrink; D M Wingerchuk; C J Klein; E Atkinson; P C O'Brien; C T McMurray
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement.

Authors:  K Minden; E Aganna; M F McDermott; A Zink
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

3.  Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.

Authors:  N Ravet; S Rouaghe; C Dodé; J Bienvenu; J Stirnemann; P Lévy; M Delpech; G Grateau
Journal:  Ann Rheum Dis       Date:  2006-03-28       Impact factor: 19.103

4.  Lack of evidence for an association between two genetic polymorphisms in the tumor necrosis factor receptor 1 gene and multiple sclerosis in Ashkenazi Jews.

Authors:  E Pras; I Aksentijevich; Y Shinar; D L Kastner; A Achiron
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

5.  A polymorphic microsatellite marker in the human p55 TNF receptor, CD120a.

Authors:  J Eskdale; R L Turestkaya; C Armstrong; D V Kuprash; S A Nedospasov; G Gallagher
Journal:  Genes Immun       Date:  2000-02       Impact factor: 2.676

6.  Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease.

Authors:  Zahir Amoura; Catherine Dodé; Sophie Hue; Sophie Caillat-Zucman; Seiamak Bahram; Marc Delpech; Gilles Grateau; Bertrand Wechsler; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2005-02

7.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

8.  Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS).

Authors:  P Lamprecht; F Moosig; S Adam-Klages; U Mrowietz; E Csernok; M Kirrstetter; K Ahmadi-Simab; J O Schroder; W L Gross
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 9.  The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.

Authors:  Keith M Hull; Elizabeth Drewe; Ivona Aksentijevich; Harjot K Singh; Kondi Wong; Elizabeth M McDermott; Jane Dean; Richard J Powell; Daniel L Kastner
Journal:  Medicine (Baltimore)       Date:  2002-09       Impact factor: 1.889

10.  Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness--the ECTIM, AXA, EVA and GENIC Studies.

Authors:  Odette Poirier; Viviane Nicaud; Jérôme Gariépy; Dominique Courbon; Alexis Elbaz; Caroline Morrison; Franck Kee; Alun Evans; Dominique Arveiler; Pierre Ducimetière; Pierre Amarenco; François Cambien
Journal:  Eur J Hum Genet       Date:  2004-03       Impact factor: 4.246
  10 in total
  4 in total

1.  TNFRSF1A [corrected] R92Q mutation, autoinflammatory symptoms and multiple sclerosis in a cohort from Argentina.

Authors:  Marcelo A Kauffman; Dolores Gonzalez-Morón; Orlando Garcea; Andrés María Villa
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

2.  Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene.

Authors:  M A Pelagatti; A Meini; R Caorsi; M Cattalini; S Federici; F Zulian; G Calcagno; A Tommasini; G Bossi; M P Sormani; F Caroli; A Plebani; I Ceccherini; A Martini; M Gattorno
Journal:  Arthritis Rheum       Date:  2011-04

3.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.

Authors:  Philip L De Jager; Xiaoming Jia; Joanne Wang; Paul I W de Bakker; Linda Ottoboni; Neelum T Aggarwal; Laura Piccio; Soumya Raychaudhuri; Dong Tran; Cristin Aubin; Rebeccah Briskin; Susan Romano; Sergio E Baranzini; Jacob L McCauley; Margaret A Pericak-Vance; Jonathan L Haines; Rachel A Gibson; Yvonne Naeglin; Bernard Uitdehaag; Paul M Matthews; Ludwig Kappos; Chris Polman; Wendy L McArdle; David P Strachan; Denis Evans; Anne H Cross; Mark J Daly; Alastair Compston; Stephen J Sawcer; Howard L Weiner; Stephen L Hauser; David A Hafler; Jorge R Oksenberg
Journal:  Nat Genet       Date:  2009-06-14       Impact factor: 38.330

4.  Involvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders.

Authors:  Isabelle Jéru; Serge Charmion; Emmanuelle Cochet; Bruno Copin; Philippe Duquesnoy; Maria Teresa Mitjavila Garcia; Gaëlle Le Borgne; Pascal Cathebras; Jacques Gaillat; Sonia Karabina; Catherine Dodé; Peter Lohse; Véronique Hentgen; Serge Amselem
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.